The latest call
FetchingBrainsway Ltd. reported on 2026年11月10日. We are fetching the call transcript; its summary follows once the transcript is in.
US$10.11-1.4%11月13日 收盘
数据截至2026年9月30日,来自2026年11月10日提交的6-K
截至 2026年9月30日 的季度,与去年同季度相比。
| 指标 | 截至该日的 3 个月2026年9月30日 | 截至该日的 3 个月2025年9月30日 | 变动 |
|---|---|---|---|
| 营业收入合计 | US$18.1M | US$13.5M | +34.30% |
| 利润 | US$2.2M | US$1.6M | +41.89% |
| 每股收益 | US$0.05 | US$0.04 | +25.00% |
这些是单季度数字,不是滚动一年——本站其他地方的数字覆盖十二个月,会大得多。季节性业务在两者之间摆动很大:ServiceNow 在十二月季度赚 20 亿美元自由现金流,在六月季度只有 5 亿。
对比对象是去年同一季度,而不是分析师预测。要说“超预期”或“不及预期”需要一致预期数据,那是我们没有的授权数据——而搞错它比不提更糟。
Brainsway Ltd. reported on 2026年11月10日. We are fetching the call transcript; its summary follows once the transcript is in.
“Our third-quarter results demonstrate our ability to translate strong revenue growth into higher profitability and cash generation. Revenue increased 34%, while operating income grew 107% and operating cash flow reached $6.2 million,”
逐字引自公告,且只在文件将其归于具名人士时才展示。
BrainsWay is a global leader in advanced noninvasive neurostimulation treatments for mental health disorders. The Company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. BrainsWay is the first and only TMS company to obtain three FDA-cleared indications backed by pivotal clinical studies demonstrating clinically proven efficacy. Current indications include major depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. The Company is dedicated to leading through superior science and building on its unparalleled body of clinical evidence. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. Founded in 2003, with operations in the United States and Israel, BrainsWay is committed to increasing global awareness of and broad access to Deep TMS. For the latest news and information about BrainsWay, please visit www.brainsway.com.
公司自己的描述,取自公告末尾。
引述和公司简介来自 Brainsway Ltd. 于 2026年11月10日 随业绩提交的 6-K 文件;表格根据其季度报告编制。 在 EDGAR 上阅读公告 股价已按拆股和分红复权。